Your browser doesn't support javascript.
loading
Randomized Trial of Primary PCI with or without RoutineManual Thrombectomy
Jolly, S S; Cairns, J A; Yusuf, S; Meeks, B; Pogue, J; Rokoss, M J; Kedev, S; Thabane, L; Stankovic, G; Moreno, R; Gershlick, A; Chowdhary, S; Lavi, S; Niemelä, K; Steg, P G; Bernat, I; Xu, Y; Cantor, W J; Overgaard, C B; Naber, C K; Cheema, A N; Welsh, R C; Bertrand, O F; Avezum, A; Bhindi, R; Pancholy, S; Rao, S V; Natarajan, M K; ten Berg, J M; Shestakovska, O; Gao, P; Widimsky, P; Džavík, V.
Afiliación
  • Jolly, S S; McMaster University. Hamilton. CA
  • Cairns, J A; University of British Columbia. Vancouver. CA
  • Yusuf, S; McMaster University. Hamilton. CA
  • Meeks, B; McMaster University. Hamilton. CA
  • Pogue, J; McMaster University. Hamilton. CA
  • Rokoss, M J; McMaster University. Hamilton. CA
  • Kedev, S; University Clinic of Cardiology. Skopje. MK
  • Thabane, L; McMaster University. Hamilton. CA
  • Stankovic, G; University of Belgrade. Belgrado. RS
  • Moreno, R; University Hospital La Paz. Madri. ES
  • Gershlick, A; University Hospitals of Leicester. Leicester. GB
  • Chowdhary, S; Manchester Academic Health Science Centre. Manchester. GB
  • Lavi, S; London Health Sciences Centre. London. CA
  • Niemelä, K; Tampere University Hospital. Tampere. FI
  • Steg, P G; Universite Paris Diderot. Paris. FR
  • Bernat, I; University Hospital and Faculty of Medicine Pilsen. Pilsen. CZ
  • Xu, Y; Tongji University. Shangai. CN
  • Cantor, W J; Southlake Regional Health Centre. Newmarket. CA
  • Overgaard, C B; Peter Munk Cardiac Centre. Toronto. CA
  • Naber, C K; Contilla Heart and Vascular Center. Essen. DE
  • Cheema, A N; St Michaels Hospital. Toronto. CA
  • Welsh, R C; Mazankowski Alberta Heart Institute. Edmonton. CA
  • Bertrand, O F; Quebec Heart Lung Institute. Quebec. CA
  • Avezum, A; Inatituto Dante Pazzanese de Cardiologia. São Paulo. BR
  • Bhindi, R; Royal North Shore Hospital. Sydney. AU
  • Pancholy, S; Northeast Clinical Trials Group. Scranton. US
  • Rao, S V; Duke Clinical Research Institute. Durham. GB
  • Natarajan, M K; McMaster University. Hamilton. CA
  • ten Berg, J M; Saint-Antonius Hospital. Nieuwegein. NL
  • Shestakovska, O; McMaster University. Hamilton. CA
  • Gao, P; McMaster University. Hamilton. CA
  • Widimsky, P; University Hospital Kralovske Vinohrady. Prague. CZ
  • Džavík, V; Peter Munk Cardiac Centre. Toronto. CA
N. Engl. j. med ; 372(15): 1389-1398, 2015. ilus
Article en En | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1064877
Biblioteca responsable: BR79.1
Ubicación: BR79.1
ABSTRACT
During primary percutaneous coronary intervention (PCI), manual thrombectomymay reduce distal embolization and thus improve microvascular perfusion. Smalltrials have suggested that thrombectomy improves surrogate and clinical outcomes,but a larger trial has reported conflicting results.MethodsWe randomly assigned 10,732 patients with ST-segment elevation myocardial infarction(STEMI) undergoing primary PCI to a strategy of routine upfront manualthrombectomy versus PCI alone. The primary outcome was a composite of deathfrom cardiovascular causes, recurrent myocardial infarction, cardiogenic shock, orNew York Heart Association (NYHA) class IV heart failure within 180 days. The keysafety outcome was stroke within 30 days.ResultsThe primary outcome occurred in 347 of 5033 patients (6.9%) in the thrombectomygroup versus 351 of 5030 patients (7.0%) in the PCI-alone group (hazard ratio in thethrombectomy group, 0.99; 95% confidence interval [CI], 0.85 to 1.15; P = 0.86). Therates of cardiovascular death (3.1% with thrombectomy vs. 3.5% with PCI alone;hazard ratio, 0.90; 95% CI, 0.73 to 1.12; P = 0.34) and the primary outcome plusstent thrombosis or target-vessel revascularization (9.9% vs. 9.8%; hazard ratio,1.00; 95% CI, 0.89 to 1.14; P = 0.95) were also similar. Stroke within 30 days occurredin 33 patients (0.7%) in the thrombectomy group versus 16 patients (0.3%)in the PCI-alone group (hazard ratio, 2.06; 95% CI, 1.13 to 3.75; P = 0.02).ConclusionsIn patients with STEMI who were undergoing primary PCI, routine manual thrombectomy,as compared with PCI alone, did not reduce the risk of cardiovasculardeath, recurrent myocardial infarction, cardiogenic shock, or NYHA class IV heartfailure within 180 days but was associated with an increased rate of stroke within30 days. (Funded by Medtronic and the Canadian Institutes of Health Research;TOTAL ClinicalTrials.gov number, NCT01149044.
Asunto(s)
Buscar en Google
Colección: 06-national / BR Base de datos: SES-SP / SESSP-IDPCPROD Asunto principal: Trombectomía / Intervención Coronaria Percutánea / Infarto Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: N. Engl. j. med Año: 2015 Tipo del documento: Article
Buscar en Google
Colección: 06-national / BR Base de datos: SES-SP / SESSP-IDPCPROD Asunto principal: Trombectomía / Intervención Coronaria Percutánea / Infarto Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: N. Engl. j. med Año: 2015 Tipo del documento: Article